Next AACT Section Webinar scheduled for December 1, 2020 at 1:00 pm Eastern

This content is for members. To join or renew, please click here.

Log In

Read More...

SLC Virtual Roundtable on December 2, 2020 – Recent Experiences Planning Virtual Scientific Meetings

Register Here Wednesday, December 2, 2020 at 11:00 AM—12:30 PM Eastern Speakers: Kirk L. Cumpston, DO President of the American Academy of Clinical Toxicology Elise Madison Lewis, PhD President of the Society for Birth Defects Research and Prevention Lawrence D. Sloan, CAE CEO of the…

Read More...

AACT Position Statement on the Benadryl® Challenge

Recently there have been reports of severe adverse outcomes after social media popularized “Benadryl® Challenge.”  Diphenhydramine, often sold under the brand name Benadryl®, is a powerful antihistamine that is available over the counter.  Individuals have intentionally ingested large amounts of diphenhydramine while recording the effects…

Read More...

AACT announces a new strategic plan and revised mission.

PRESS RELEASE For Immediate Release July 2020 McLean, VA – The American Academy of Clinical Toxicology has announced a new strategic plan and revised mission statement. AACT’s new mission statement is to champion the advancement of treatment, research, education, and prevention of poisoning injury caused by…

Read More...

News Regarding AACT Member J. Ward Donovan

J. Ward Donovan died peacefully surrounded by his family on June 27, 2020 after courageously battling cancer. Ward was a pioneer and natural leader in Emergency Medicine and Medical Toxicology. Ward completed his residency in Emergency Medicine at M.S. Hershey Medical Center and in a few short…

Read More...

AACT & ACMT Partner for COVID Webinar Series

In response to the COVID-19 pandemic, AACT is collaborating with ACMT in addition to other national and international partner societies as well as members of the Global Clinical Toxicology Community to offer periodic web-based presentations, panel discussions, and briefings. Subject-matter experts and practitioners, many of…

Read More...

Follow Up Message from AACT’s President, June 5, 2020

05 June 2020 Dear AACT members,After my remarks the other day, I received overwhelmingly positive comments, and I thank you for them. There has been some confusion among a few members as to why I would use the platform of AACT president to espouse what…

Read More...

A Message from the AACT President, June 2, 2020

02 June 2020   Dear AACT Members, While AACT leadership has spent the past month fretting about NACCT and how we would pull off a fully remote meeting, whining that we won’t get to see everybody in person this fall, things have really been put…

Read More...

Update on NACCT 2020

Update on NACCT 2020 19 May 2020   Dear friends and colleagues, The Board of Trustees for the American Academy of Clinical Toxicology (AACT) met yesterday and have determined that this September’s meeting of the North American Congress of Clinical Toxicology (NACCT) will be a…

Read More...

AACT Joint Statement Caution About Toxicity From Hydroxychloroquine and Chloroquine

FOR IMMEDIATE RELEASE The American Academy of Clinical Toxicology, The American College of Medical Toxicology and the American Association of Poison Control Centers Caution About Toxicity From Hydroxychloroquine and Chloroquine. McLean, VA — March 30, 2020 — There are currently no medications or vaccines proven to be effective for the direct treatment…

Read More...

Site Search